Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A cancer protein’s journey to cell membrane

11.04.2014

KRas moves between various membranes within the cell, so that it is available in a sufficient quantity at its actual destination

The cancer protein KRas is a factor in the development of several types of cancer. Mutated KRas, for example, can be found in a large number of all tumour cells in patients with pancreatic cancer. It sits on the inner leaflet of the cell membrane and relays signals into the cell’s interior.


Distribution of the cancer protein KRas in a cell.

© M. Schmick

Scientists at the Max Planck Institute of Molecular Physiology in Dortmund have now discovered why KRas is almost exclusively found at the cell membrane when observed under the microscope. Apparently, the protein is not specifically sent to the cell membrane after it is formed, but is also located on other membrane systems within the cell for its entire life span.

In order for it to be transported by special transport vesicles from the vicinity of the cell nucleus to the cell membrane, the solubilising factor PDEδ and its antagonist Arl2 must be active. Without the two of them, KRas would spread to cell membranes. The researchers can use their results to better understand how deltarasin works, which is a potential anti-cancer drug that they have developed.

The protein KRas acts as a molecular switch in relaying signals to the cell’s interior. Among other things, such signals control cell growth. In order for KRas to be able to function correctly, it must remain on the inner leaflet of the cell membrane for a sufficient period of time. Its water-insoluble lipid anchor helps it to achieve this.

However, this also anchors the protein to other intracellular membranes. KRas therefore has an area of positive charges near this lipid anchor. Similar to a polystyrene ball in a plastic bag, the electrostatic interaction of these positive charges with the negatively charged inner leaflet of the cell membrane reinforces the lipid anchoring.

But even lipid anchor and positive charges are not enough to ensure that KRas is permanently enriched at the cell membrane. According to the results obtained by the researchers in Dortmund, many KRas molecules would still be lost on the available surface of the rest of the membrane systems in the cell, which is 200 times bigger than that of the cell membrane. Using complex computer simulations, the scientists evaluated data from fluorescence microscopy experiments and tracked the movement of KRas on its journey though the cell.

“Our results show that the cell membrane is by no means the final destination of KRas, which must only be encountered once. Instead, KRas constantly and unspecifically re-distributes to the various membrane systems of the cell and must then be concentrated on the inner leaflet of the cell membrane via a continuous cycle,” explains Malte Schmick from the Max Planck Institute of Molecular Physiology.

In the first step of this cycle, the soluble protein PDEδ shields the lipid anchor of KRas like a glove, thus making KRas water-soluble. This prevents KRas from simply finding some arbitrary membrane. Swimming in the cytoplasm, KRas can thus explore the cell. When it gets close to the nucleus of the cell, the activity of the protein Arl2 removes this glove. KRas is now insoluble in water again and can be trapped on membranes and transported back to the cell membrane by vesicles.

The cell therefore does not have a unique targeting system for KRas, which sends it exclusively to the cell membrane. Instead, the protein redistributes to all membranes and is repeatedly sorted from the wrong membranes to the correct one. “Each KRas molecule lives for several hours before the cell disassembles it again. After seven minutes, half of all KRas molecules are internalized from the cell membrane to be subjected to the cycle and sent back to the cell membrane. In total, each KRas molecule travels for approximately 20 minutes before it reaches the cell membrane again,” says Schmick.

The results obtained by the scientists in Dortmund pave the way for the development of new cancer drugs. This is due to the fact that KRas is modified in many forms of cancer to such an extent that it is permanently active and the cell can no longer switch it off. One-third of all tumours contain cells with mutations of Ras proteins. In the case of intestinal cancer for example, mutated KRas prevents successfully using antibody treatment against epidermal growth factor receptors (EGFR).

“We can now develop active agents that reduce the enrichment of mutated, permanently active KRas at the cell membrane,” explains Philippe Bastiaens, Director at the Max Planck Institute in Dortmund. In 2013, he worked with colleagues Herbert Waldmann and Alfred Wittinghofer to develop an inhibitor, known as deltarasin, to block the PDEδ solubilizing activity. Initial experiments on mice have shown that the active agent considerably slows the growth of tumours. Even though scientists had been aware of the relevance of PDEδ for a while, this work now explains for the first time the mechanism by which deltarasin prohibits KRas from being enriched at the cell membrane and causes it to be distributed throughout the entire cell.

Contact 

Prof. Dr. Philippe Bastiaens
Max Planck Institute of Molecular Physiology, Dortmund
Phone: +49 231 1332-200
Fax: +49 231 1332-299
Email:philippe.bastiaens@mpi-dortmund.mpg.de
 
Dr. Peter Herter
Max Planck Institute of Molecular Physiology, Dortmund
Phone: +49 231 133-2500
Fax: +49 231 133-2599 

Original publication

 
Malte Schmick, Nachiket Vartak, Björn Papke, Marija Kovacevic, Dina C. Truxius, Lisaweta Rossmannek, Philippe I.H. Bastiaens
KRas localizes to the plasma membrane by spatial cycles of solubilization, trapping and vesicular transport
Cell, 10 April 2014

Prof. Dr. Philippe Bastiaens | Max-Planck-Institut

Further reports about: Molecular Physiology anchor experiments factor signals tumours vesicles

More articles from Life Sciences:

nachricht Fine organic particles in the atmosphere are more often solid glass beads than liquid oil droplets
21.04.2017 | Max-Planck-Institut für Chemie

nachricht Study overturns seminal research about the developing nervous system
21.04.2017 | University of California - Los Angeles Health Sciences

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

Im Focus: Quantum-physical Model System

Computer-assisted methods aid Heidelberg physicists in reproducing experiment with ultracold atoms

Two researchers at Heidelberg University have developed a model system that enables a better understanding of the processes in a quantum-physical experiment...

Im Focus: Glacier bacteria’s contribution to carbon cycling

Glaciers might seem rather inhospitable environments. However, they are home to a diverse and vibrant microbial community. It’s becoming increasingly clear that they play a bigger role in the carbon cycle than previously thought.

A new study, now published in the journal Nature Geoscience, shows how microbial communities in melting glaciers contribute to the Earth’s carbon cycle, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

New quantum liquid crystals may play role in future of computers

21.04.2017 | Physics and Astronomy

A promising target for kidney fibrosis

21.04.2017 | Health and Medicine

Light rays from a supernova bent by the curvature of space-time around a galaxy

21.04.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>